How Secreted-embryo-derived Trypsin Initiates, Maintains and Terminates Ca2+ Signals in Uterine Epithelial Cells

NCT04865367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2024-07-17

No results posted yet for this study

Summary

To develop a deeper understanding of endometrial-embryo crosstalk through basic research, uncover therapeutic targets and to improve reproductive outcome.

Conditions

Interventions

OTHER

Exposure to culture media

Exposure to culture media

Sponsors & Collaborators

  • University Women's Hospital Tübingen

    collaborator OTHER
  • ART Fertility Clinics LLC

    lead OTHER

Principal Investigators

  • BARBARA LAWRENZ, PhD · ART Fertility Clinics LLC

Eligibility

Min Age
18 Years
Max Age
36 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-04
Primary Completion
2023-04-16
Completion
2023-05-15

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04865367 on ClinicalTrials.gov